Broadcom Limited (AVGO) PT Raised to $462 at Morgan Stanley

Morgan Stanley analyst Joseph Moore raised the price target on Broadcom Limited (NASDAQ: AVGO) to $462.00 (from $443.00) while maintaining a Overweight rating.

The analyst comments: "Overall, these are very good results, showing near term upside to overall #s for the first time in a while. Every quarter in CY25 has driven longer term expectations higher, as they have expanded from 3 customers to 5, given optimistic SAM targets for CY27, amid positive reports on TPU v7; AI revenues have been above our estimates, mostly offset by weaker non AI semis. This quarter showed more of a short term inflection as well, guiding overall revenues and EPS further above our estimates than we had seen previously, and guiding AI 20% above our estimates for the January quarter. That said, the very strong revenue from Anthropic for 2h26 does create some uncertainties in how to model all of this growth. Last quarter the company announced a $10 bn order from customer #4, later officially revealed to be Anthropic, and tonight the company announced another $11 bn order from them. Both of those orders ship in 2h26; $21 bn of revenue is over 40% of our full year AI #."

You May Also Be Interested In

• HDFC Asset Management Co Ltd (HDFCAMC:IN) PT Raised to INR3,250 at JPMorgan
• JPMorgan Starts Computer Age Management Services (CAMS:IN ) at Overweight
• Taysha Gene Therapies (TSHA) PT Raised to $10 at BofA Securities